No, we really don't. There are some medications which can reduce schizophrenia symptoms but patient compliance is generally low because the side effects are so

No, we really don't. There are some medications which can reduce schizophrenia symptoms but patient compliance is generally low because the side effects are so bad. Those medications are already widely available to patients willing to take them. So I fail to see what that has to do with OpenAI.